[HTML][HTML] Mechanisms of resistance to conventional therapies for osteosarcoma
L Marchandet, M Lallier, C Charrier, M Baud'huin… - Cancers, 2021 - mdpi.com
Simple Summary Osteosarcoma (OS), the most common primary bone tumor, mainly affects
children and adolescents. Unfortunately, in some cases, the absence of response to …
children and adolescents. Unfortunately, in some cases, the absence of response to …
Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal
S Li, W Sun, H Wang, D Zuo, Y Hua, Z Cai - Tumor Biology, 2015 - Springer
Osteosarcoma (OS) is the most common and aggressive primary malignant type of bone
cancer in children and adolescents. Chemotherapy is one of the most important treatments …
cancer in children and adolescents. Chemotherapy is one of the most important treatments …
[HTML][HTML] Recent insights into therapy resistance in osteosarcoma
ZD Prudowsky, JT Yustein - Cancers, 2020 - mdpi.com
Simple Summary Osteosarcoma is the most common cancer of the bone for children and
adolescents. Although chemotherapy regimens have been widely available and effective for …
adolescents. Although chemotherapy regimens have been widely available and effective for …
[HTML][HTML] Targeting molecular mechanisms underlying treatment efficacy and resistance in osteosarcoma: a review of current and future strategies
I Lilienthal, N Herold - International journal of molecular sciences, 2020 - mdpi.com
Osteosarcoma is the most common primary malignant bone tumour in children and
adolescents. Due to micrometastatic spread, radical surgery alone rarely results in cure …
adolescents. Due to micrometastatic spread, radical surgery alone rarely results in cure …
Chemotherapy resistance in osteosarcoma: current challenges and future directions
AJ Chou, R Gorlick - Expert review of anticancer therapy, 2006 - Taylor & Francis
For patients with osteosarcoma, the use of chemotherapy has improved survival from 11%
with surgical resection alone in the 1960s, to 70% by the mid-1980s. However, survival has …
with surgical resection alone in the 1960s, to 70% by the mid-1980s. However, survival has …
[HTML][HTML] Drug resistance in osteosarcoma: emerging biomarkers, therapeutic targets and treatment strategies
CM Hattinger, MP Patrizio, L Fantoni, C Casotti… - Cancers, 2021 - mdpi.com
Simple Summary Despite the adoption of aggressive, multimodal treatment schedules, the
cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 …
cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 …
[HTML][HTML] Molecular mechanisms of chemoresistance in osteosarcoma
H He, J Ni, JUN Huang - Oncology letters, 2014 - spandidos-publications.com
Due to the emergence of adjuvant and neoadjuvant chemotherapy, the survival rate has
been greatly improved in osteosarcoma (OS) patients with localized disease. However, this …
been greatly improved in osteosarcoma (OS) patients with localized disease. However, this …
[HTML][HTML] Origin and therapies of osteosarcoma
B Moukengue, M Lallier, L Marchandet, M Baud'huin… - Cancers, 2022 - mdpi.com
Simple Summary Osteosarcoma is the most common malignant bone tumor in children, with
a 5-year survival rate ranging from 70% to 20% depending on the aggressiveness of the …
a 5-year survival rate ranging from 70% to 20% depending on the aggressiveness of the …
Therapy for osteosarcoma: where do we go from here?
AJ Chou, DS Geller, R Gorlick - Pediatric Drugs, 2008 - Springer
Osteosarcoma is the most common malignant primary bone tumor in children and
adolescents. Current optimal treatment for osteosarcoma consists of multi-agent …
adolescents. Current optimal treatment for osteosarcoma consists of multi-agent …
Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group
CL Schwartz, R Gorlick, L Teot, M Krailo… - Journal of clinical …, 2007 - ascopubs.org
Purpose Multiple drug resistance due to P-glycoprotein (P-gp) expression has been
reported to be a cause of disease recurrence in osteosarcoma. Tumor specimens derived …
reported to be a cause of disease recurrence in osteosarcoma. Tumor specimens derived …